ES2032812T3 - Vacuna. - Google Patents
Vacuna.Info
- Publication number
- ES2032812T3 ES2032812T3 ES198787201620T ES87201620T ES2032812T3 ES 2032812 T3 ES2032812 T3 ES 2032812T3 ES 198787201620 T ES198787201620 T ES 198787201620T ES 87201620 T ES87201620 T ES 87201620T ES 2032812 T3 ES2032812 T3 ES 2032812T3
- Authority
- ES
- Spain
- Prior art keywords
- proteins
- auxiliary
- protein
- picornavirus
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 241000709664 Picornaviridae Species 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000991587 Enterovirus C Species 0.000 abstract 1
- 101001059240 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Site-specific recombinase Flp Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
LA INVENCION SE REFIERE A UNA NUEVA VACUNA QUE CONTIENE UNA PROTEINA NATURAL CAPAZ DE INDUCIR LA FORMACION DE ANTICUERPOS PROTECTORES EN UN HUESPED, JUNTO CON UNA CANTIDAD DE CIERTAS PROTEINAS O PEPTIDOS AUXILIARES QUE, COMO TALES, NO SON CAPACES DE INDUCIR CONCENTRACIONES IMPORTANTES DE ANTICUERPOS PROTECTORES, PERO QUE MEJORAN CONSIDERABLEMENTE LA ACTIVIDAD INMUNIZANTE DE DICHA PROTEINA NATURAL. LAS SECUENCIAS DE AMINOACIDOS DE LAS PROTEINAS Y PEPTIDOS AUXILIARES MUESTRAN HOMOLOGIA CON LAS PROTEINAS NATURALES. LA COMBINACION DE PICORNAVIRUS DESACTIVADO, TAL COMO POLIOVIRUS, CON CANTIDADES AUXILIARES DE PICORNAVIRUS DESNATURALIZADO, TAL COMO POLIOVIRUS, PROTEINAS CAPSIDO, EN UNA VACUNA ES ALTAMENTE VENTAJOSA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/900,739 US4946676A (en) | 1986-08-27 | 1986-08-27 | Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2032812T3 true ES2032812T3 (es) | 1993-03-01 |
Family
ID=25413018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198787201620T Expired - Lifetime ES2032812T3 (es) | 1986-08-27 | 1987-08-27 | Vacuna. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4946676A (es) |
EP (1) | EP0257721B1 (es) |
JP (1) | JPS63132844A (es) |
AT (1) | ATE71534T1 (es) |
CA (1) | CA1292690C (es) |
DE (1) | DE3776034D1 (es) |
DK (1) | DK169276B1 (es) |
ES (1) | ES2032812T3 (es) |
GR (1) | GR3003754T3 (es) |
NO (1) | NO873593L (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6797270B1 (en) * | 1989-03-16 | 2004-09-28 | Center For Blood Research, Inc. | Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
CA2105629A1 (en) * | 1992-09-14 | 1994-03-15 | Robert S. Becker | Potentiation of immunogenic response |
EP1409551A4 (en) * | 2001-06-21 | 2004-10-13 | Uab Research Foundation | CHEMICAL CAPSIDE PROTEINS AND USES THEREOF |
US20040002058A1 (en) * | 2001-06-21 | 2004-01-01 | Uab Research Foundation | Chimeric capsid proteins and uses thereof |
US20090142364A1 (en) * | 2007-08-30 | 2009-06-04 | Fedor Alexandrovich Brovko | Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use |
EP3307311A4 (en) | 2015-06-15 | 2019-02-13 | Emory University | MULTIVALENT ENTEROVIRUS VACCINE COMPOSITIONS AND USES THEREOF |
CN110603046B (zh) * | 2016-03-20 | 2022-10-18 | 宾夕法尼亚州立大学托管会 | 用于提高高等植物叶绿体中转基因表达的密码子优化和核糖体图谱分析 |
-
1986
- 1986-08-27 US US06/900,739 patent/US4946676A/en not_active Expired - Lifetime
-
1987
- 1987-08-26 NO NO873593A patent/NO873593L/no unknown
- 1987-08-26 DK DK446287A patent/DK169276B1/da active
- 1987-08-27 CA CA000545494A patent/CA1292690C/en not_active Expired - Lifetime
- 1987-08-27 EP EP87201620A patent/EP0257721B1/en not_active Expired - Lifetime
- 1987-08-27 ES ES198787201620T patent/ES2032812T3/es not_active Expired - Lifetime
- 1987-08-27 AT AT87201620T patent/ATE71534T1/de not_active IP Right Cessation
- 1987-08-27 DE DE8787201620T patent/DE3776034D1/de not_active Expired - Lifetime
- 1987-08-27 JP JP62214131A patent/JPS63132844A/ja active Pending
-
1992
- 1992-02-11 GR GR920400176T patent/GR3003754T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK169276B1 (da) | 1994-10-03 |
EP0257721A2 (en) | 1988-03-02 |
DK446287D0 (da) | 1987-08-26 |
EP0257721A3 (en) | 1988-06-08 |
DE3776034D1 (de) | 1992-02-27 |
CA1292690C (en) | 1991-12-03 |
DK446287A (da) | 1988-02-28 |
JPS63132844A (ja) | 1988-06-04 |
GR3003754T3 (es) | 1993-03-16 |
EP0257721B1 (en) | 1992-01-15 |
NO873593D0 (no) | 1987-08-26 |
NO873593L (no) | 1988-02-29 |
US4946676A (en) | 1990-08-07 |
ATE71534T1 (de) | 1992-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68924162D1 (de) | Stressproteine und verwendungen dafür. | |
GB1531762A (en) | Cancer antigen cancer therapy and cancer diagnosis | |
NO894503D0 (no) | Uretan-beskyttede aminosyre-n-karboksyanhydrider. | |
NL300106I1 (nl) | N-terminaal chemisch gemodificeerde eiwitpreparaten en werkwijzen. | |
ATE295416T1 (de) | Humanisiertes grünes-fluoreszenzprotein und methoden | |
DE69231469T2 (de) | Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen | |
DK0561907T3 (da) | Proteiner med ændrede epitoper og fremgangsmåder til fremstilling deraf | |
HUP0302965A2 (hu) | Vakcina | |
DE68929043T2 (de) | Für androgen-rezeptor-protein kodierende dna | |
GEP19981289B (en) | Method for Preparing Preserved Medicinal Means Containing Human Protein and Medicinal Means | |
NZ227788A (en) | Peptide having growth hormone regulatory effects, and compositions | |
MX9206041A (es) | Proceso para producir interferon inmune humano. | |
DK215287A (da) | Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette | |
ATE273997T1 (de) | Zyklische hexapeptid somatostatin analoga | |
DK110190D0 (da) | Alveolaere surfaktantproteiner | |
ES2032812T3 (es) | Vacuna. | |
DE3685651D1 (de) | Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide. | |
HUP9900506A2 (hu) | Protrombinszármazékok | |
DE60118359D1 (de) | Humanische pellino-polypeptide | |
ES2044881T3 (es) | Procedimiento para la preparacion de una fosfoproteina estructural (pp 150) del citomegalovirus humano. | |
EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
NO930428D0 (no) | Proteinstrukturen til plantetoksingelonin | |
ES2143996T3 (es) | Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv. | |
AR006150A1 (es) | Proteina de via complementaria natural modificada capaz de formar una convertasa c3 resistente a la regulacion descendente, secuencias de adn quecodifican dicha proteina, usos de dicha proteina y composiciones que la contienen | |
NO942360L (no) | Vaksine og polypeptider som er nyttige for denne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 257721 Country of ref document: ES |